gms | German Medical Science

67th Annual Meeting of the German Society of Neurosurgery (DGNC)
Joint Meeting with the Korean Neurosurgical Society (KNS)

German Society of Neurosurgery (DGNC)

12 - 15 June 2016, Frankfurt am Main

Early and aggressive treatment improves outcome after high-grade (Hunt&Hess Grade 5) subarachnoid hemorrhage: a high-volume single-center cohort comparison of a pre-coiling-era (1980–1995) vs. post-ISAT-era (2005–2014)

Meeting Abstract

  • Juergen Konczalla - Universitätsklinikum Frankfurt, Goethe-Universität, Klinik und Poliklinik für Neurochirurgie, Frankfurt, Germany
  • Volker Seifert - Universitätsklinikum Frankfurt, Goethe-Universität, Klinik und Poliklinik für Neurochirurgie, Frankfurt, Germany
  • Hartmut Vatter - Rheinische Friedrich-Wilhelms-Universität, Klinik und Poliklinik für Neurochirurgie, Bonn, Germany
  • Andreas Raabe - Universitätsklinik Bern, Inselspital, Neurochirurgische Klinik, Bern, Switzerland
  • Gerhard Marquardt - Universitätsklinikum Frankfurt, Goethe-Universität, Klinik und Poliklinik für Neurochirurgie, Frankfurt, Germany

Deutsche Gesellschaft für Neurochirurgie. 67. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 1. Joint Meeting mit der Koreanischen Gesellschaft für Neurochirurgie (KNS). Frankfurt am Main, 12.-15.06.2016. Düsseldorf: German Medical Science GMS Publishing House; 2016. DocMO.09.04

doi: 10.3205/16dgnc035, urn:nbn:de:0183-16dgnc0355

Published: June 8, 2016

© 2016 Konczalla et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objective: Whereas outcome data for severe (Hunt & Hess (H&H) Grade 4+5) subarachnoid hemorrhage (SAH) exists, outcome analysis of comatose patients (H&H Grade 5) is still missing. During the last 35 years treatment strategies (early vs. late clipping vs. no treatment), treatment modalities (clipping alone vs. coiling or clipping with ICG-angiography), diagnosis and treatment of cerebral vasospasm and intensive-care-unit standards changed partially dramatically. The aim of the study was to compare the outcome of patients with SAH H&H Grade 5 between these two periods.

Method: We retrospectively analyzed patients with SAH H&H Grade 5 between 1980-1995 (earlier period) compared to 2005-2014 (actual period). Outcome of 257 patients was analyzed and stratified using the modified Rankin Scale (favorable (mRS 0-2) and unfavorable (3-6)) six months after SAH.

Results: In the earlier period 54 patients of the admitted patients had a SAH H&H Grade 5 compared to 203 patients in the actual period. In the earlier period 50% of the aneurysms were located in the anterior circulation, 7% in the posterior circulation and in 30% a diagnostic DSA was not performed, compared to 70% anterior, 20% posterior circulation and 6% w/o DSA in the actual period (P<0,01). In the earlier period 33% received an external ventricular drainage (EVD) compared to 79% in the actual period (P<0,01). In the earlier period 74% did not receive any treatment (vs. 32% actual period; P<0,01). Early aneurysm treatment within 48h occurred significantly more often in the actual period (P<0,01; OR 7.6). In the earlier period patients had a significant higher 30-day mortality rate (83% vs. 39%; OR 7.7) and 6-months-mortality rate (94% vs. 49%; OR 17.9). Whereas in the earlier period no patients had a favorable outcome, in the actual period 23% of patients (P<0,01; OR 32.0), respectively 29% of the aneurysm-treated patients (P<0,01; OR 219) had a favorable outcome. Of the treated patients the NNT (number needed to treat) is 2 for survival and 4 for favorable outcome in the actual period. In the actual period favorable outcome was similar often in both treatment modalities (29% clip vs. 31% coil).

Conclusions: Early and aggressive treatment (early insertion of vital EVD and early aneurysm treatment) resulted in a significant improvement in survival rate (NNT=2) and favorable outcome (NNT=4) of comatose patients with SAH (H&H Grade 5). Therefore, treatment of patients with H&H Grade 5 subarachnoid hemorrhage should be performed and not be delayed.